Works matching IS 22965270 AND DT 2016 AND VI 39 AND IP 7/8
Results: 27
Vielversprechende Studiendaten zum Anti-PD-L1-Antikörper Atezolizumab.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 483
- By:
- Publication type:
- Article
Zulassung für Patienten mit nicht resezierbarem, lokal oder entfernt metastasiertem Melanom.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 486
- By:
- Publication type:
- Article
Neue Therapieoption für vorbehandelte Patienten mit metastasiertem kolorektalem Karzinom.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 486
- Publication type:
- Article
EU-Zulassung für Afinitor<sup>®</sup> zur Behandlung Erwachsener mit bestimmten fortgeschrittenen GI- und Lungen-NET.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 485
- By:
- Publication type:
- Article
Leptomeningeale Metastasen erkennen und angemessen behandeln.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 485
- By:
- Publication type:
- Article
Boehringer Ingelheim startet ELUXA-Studienprogramm zur Untersuchung des vielversprechenden Lungenkrebs-Präparats Olmutinib.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 484
- By:
- Publication type:
- Article
Lipegfilgrastim erhält Doppelplus-Empfehlung.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 484
- By:
- Publication type:
- Article
Merck und Sysmex Inostics erhalten CE-Kennzeichnung für Flüssigbiopsie- Biomarkertest für Patienten mit Kolorektalkarzinom.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 483
- Publication type:
- Article
Lenvatinib zeigt weiterhin signifikante Verbesserungen der Wirksamkeitsparameter bei differenziertem Schilddrüsenkarzinom.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 482
- Publication type:
- Article
Nach ersten Ergebnissen der Absetzstudien ENESTfreedom und ENESTop bleiben über die Hälfte der teilnehmenden CML-Patienten in therapiefreier Remission.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 482
- By:
- Publication type:
- Article
Neue Perspektiven durch Angriff an CD38: Darzalex<sup>®</sup> überzeugt als Monotherapie.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 481
- Publication type:
- Article
Myelom-Management: inter- und multidisziplinär denken.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 479
- Publication type:
- Article
Einfalt statt Vielfalt? Zu den Plänen des GKV-Spitzenverbands für ein Arztinformationssystem zu neuen Arzneimitteln.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 477
- By:
- Publication type:
- Article
Produktionsstopp von Etopophos: DGHO erarbeitet Empfehlungen zur Sicherstellung der Versorgung.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 476
- By:
- Publication type:
- Article
Patientenrekrutierung für drei neue Studien zur Behandlung von Pankreaskrebs gestartet.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 474
- By:
- Publication type:
- Article
Präzisionsmedizin auf dem Vormarsch – Neues vom ASCO-Jahrestreffen 2016.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 473
- By:
- Publication type:
- Article
Deutsche Krebsgesellschaft gibt neue Führungsspitze bekannt – Prof. Dr. Peter Albers wird Präsident der Fachgesellschaft.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 472
- By:
- Publication type:
- Article
Ongoing Clinical Trials in Prostate Cancer: The STAMPEDE Trial.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 464, doi. 10.1159/000447341
- By:
- Publication type:
- Article
Monatsthema im August: Individualisierte Schmerztherapie.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 471
- By:
- Publication type:
- Article
ASCO-Highlights 2016.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 468, doi. 10.1159/000448324
- By:
- Publication type:
- Article
Rapid Intracranial Response to Osimertinib in a Patient with Epidermal Growth Factor Receptor T790M-Positive Adenocarcinoma of the Lung.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 461, doi. 10.1159/000446759
- By:
- Publication type:
- Article
Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 453, doi. 10.1159/000447372
- By:
- Publication type:
- Article
DNA Methyltransferase 1: A Potential Gene Therapy Target for Hepatocellular Carcinoma?
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 448, doi. 10.1159/000447414
- By:
- Publication type:
- Article
Impact of XRCC1, GSTP1, and GSTM1 Polymorphisms on the Survival of Ovarian Carcinoma Patients Treated with Chemotherapy.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 440, doi. 10.1159/000447337
- By:
- Publication type:
- Article
Risk Factors for Parametrial Involvement in Early-Stage Cervical Cancer and Identification of Patients Suitable for Less Radical Surgery.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 432, doi. 10.1159/000447335
- By:
- Publication type:
- Article
CONIFER – Non-Interventional Study to Evaluate Therapy Monitoring During Deferasirox Treatment of Iron Toxicity in Myelodysplastic Syndrome Patients with Transfusional Iron Overload.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 424, doi. 10.1159/000447035
- By:
- Publication type:
- Article
Guideline Adherence Regarding the Use of Expensive Drugs in Daily Practice: The Examples of Trastuzumab in Breast Cancer and Bortezomib in Multiple Myeloma.
- Published in:
- Oncology Research & Treatment, 2016, v. 39, n. 7/8, p. 417, doi. 10.1159/000447280
- By:
- Publication type:
- Article